With such an overwhelming response to launch of PEGS China in 2014 CHI is excited to announce its return to Shanghai for the 2nd Annual PEGS China event!
Based upon your feedback and intensive research on the hot topics that are of interest and relevance to the current state of the industry, CHI is pleased to announce that our 2nd Annual PEGS China will take place on March 31-April 2, 2015 at the Shanghai Marriott Pudong East Hotel, and will comprise of four content driven conferences delivering unpublished data, and invaluable learning and networking opportunities.
This 3-day event is the meeting place for international and domestic scientists to share case studies and project updates, showcase new techniques and form collaborations that pave the way towards the future of China’s biopharmaceutical industry.
Keynote & Featured Speakers
Antibody Development Strategies in Today’s China
Chengbin Wu, Ph.D., President, Research & Development and CSO, Shanghai C P Guojian Pharmaceutical Co. Ltd., PR China
ADC: Is It Time to Rethink Some Preconceptions?
Jaume Pons, Ph.D., Senior Vice President and CSO, Rinat- Pfizer
Current Clinical Experience with Antibody-Drug Conjugates: A View through the Therapeutic Window
Robb Kahn, M.D., Senior Safety Science Leader, Global Pediatric Oncology Drug Development, Genentech, a member of the Roche Group
2015 Conference Programs Include:
Protein & Antibody Engineering will focus on understanding structure-function relationships, engineering for better developability and reduced aggregation, and designing of new formats.
Antibody-Drug Conjugates will examine novel payloads, linker technologies and conjugation chemistries, as well as target selection and prioritization.
Phage & Yeast Display will highlight antibody discovery and screening technologies with the goal of generating antibodies with optimized efficacy and improved properties.
Characterization of Biotherapeutics will showcase technologies and methods for characterization and comparability, detecting aggregates and minimizing immunogenicity.
Attendees can choose to attend 1 or all 4 of the conferences and benefit from the expansive coverage that only this event offers!